A customer uses an automated teller machine (ATM) at a Truist Bank branch in Dallas, Texas, U.S., Friday, April 14, 2023.
Shelby Taub | Bloomberg | Getty Images
With the rise of digital services, the healthcare industry has undergone rapid changes over the past decade, bringing with it a range of investment opportunities.
TipRanks recognizes the 10 best analysts on Wall Street for identifying the best investment opportunities. These analysts outperform their peers in stock picking and generate handsome returns through their recommendations.
TipRanks utilizes its Expert Center Identify tools with a high success rate. We also analyzed every stock recommendation made by healthcare industry analysts over the past decade.
This ranking shows the ability of analysts to generate returns from their recommendations. TipRanks’ algorithm calculates the statistical significance of each rating, the average rate of return, and the analyst’s overall success rate. Additionally, each rating is measured over a one-year period.
Top 10 Analysts from the Healthcare Industry
This graph shows the most successful Wall Street analysts in the healthcare industry in descending order.
1. Thomas Smith – SVB Securities
Thomas Smith tops the list. Smith’s overall success rate is 51 percent.His best rating is live viking therapy (Nasdaq Stock Code: VKTX), a clinical-stage biopharmaceutical company focused on the treatment of metabolic and endocrine disorders. From April 27, 2022 to April 27, 2023, his buy call on VKTX stock produced an astonishing return of 791.30%.
2. Brandon Couillard-Jeffrey
Brandon Couillard comes in second on this list with a 68% success rate. Couillard’s top recommendation is exact science (NASDAQ Stock Symbol: EXAS), a company that provides cancer screening and diagnostic tests. From May 4, 2016 to May 4, 2017, the analyst made a profit of 450% on his buy recommendation on Exact Sciences stock.
3. David Windley – Jefferies
Jefferies analyst David Windley ranked No. 3 on the list. Wendley has a 68 percent success rate. His best recommendation was Medidata Solutions, a technology company with clinical expertise. Dassault Systèmes later acquired Medidata. From August 1, 2012 to August 1, 2013, analysts generated a 175.70% turnaround with Buy recommendations on MDSO.
4. John Eade – Argus Research
John Eade is fourth on the list. Five-star analysts have an overall success rate of 69%.Yide’s best recommendation is online modern (NASDAQ: MRNA), a pharmaceutical and biotechnology company. From June 30, 2020 to June 30, 2021, his buy call on MRNA stock produced a return of 265.90%.
5. Michael Wiederhorn-Oppenheimer
The fifth analyst, Michael Wiederhorn, has a 66 percent success rate.his best advice is community health system (NYSE: CYH), a company engaged in the management and operation of hospitals. From May 1, 2020, to May 1, 2021, analysts have a 298.2% coverage on the stock.
6. Charles Duncan – Cantor Fitzgerald
In sixth place is Charles – Duncan. Analysts have a 52% success rate.His top recommendation is Novaks (NASDAQ: NVAX), a biotechnology company developing vaccines. Duncan made a solid 800% return from March 17, 2020 to March 17, 2021 by buying NVAX stock.
7. Yaron Werber-TD Cowen
TD Cowen analyst Yaron Werber was seventh on the list with a 65% success rate. Werber’s best bet is to buy Ultragenyx Pharmaceuticals (Nasdaq: Rare), a biopharmaceutical company focused on developing innovative drugs for rare and ultra-rare diseases. From December 18, 2019 to December 18, 2020, this advice generated a return of 267.50%.
8. Geulah Life Hits – Chardan Capital
In eighth place is Geulah Livshits of Chardan Capital. Livshits have an overall success rate of 42%.The analyst’s top recommendation is Cabaleta Bio (NASDAQ: CABA), a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Based on her Buy rating on CABA, the analyst is up 800% from October 11, 2022 to now.
9. Richard Newitter—Truist Financial
Richard Newt is ninth on the list. Five-star analysts have a 62% success rate.His top recommendation has been organogenesis (Nasdaq: ORGO), a regenerative medicine company with products for advanced wound care and surgical biologics. From May 12, 2020 to May 12, 2021, the buy recommendation generated a return of 397.9%.
10. Bory Peak – TD Cowen
Boris Peaker ranks No. 10 on the list with a success rate of 47%. Peaker’s best bet is to buy shares of Trillium Therapeutics, a clinical-stage company developing cancer treatments. Pfizer (NYSE: PFE) Trillium was later acquired. From January 7th, 2020 to January 7th, 2021, the advice generated an 800% return.
the bottom line
Investors can make informed investment decisions based on recommendations from top analysts. You can also view all top 100 analysts. We will be returning shortly with our top 10 analysts for the consumer staples industry over the past 10 years.